Value of Hybrid Imaging with PET/CT to Guide Percutaneous Revascularization of Chronic Total Coronary Occlusion

Wijnand J Stuijfzand, Pieter G Raijmakers, Roel S Driessen, Niels van Royen, Alexander Nap, Albert C van Rossum, Paul Knaapen, Wijnand J Stuijfzand, Pieter G Raijmakers, Roel S Driessen, Niels van Royen, Alexander Nap, Albert C van Rossum, Paul Knaapen

Abstract

Chronic total coronary occlusions (CTO) are documented in approximately one fifth of diagnostic invasive coronary angiographies (ICA). Percutaneous coronary interventions (PCI) of CTO are challenging and are accompanied by higher complication and lower success rates in comparison with non-CTO PCI. Scrutinous evaluation of ischemia and viability to justify percutaneous revascularization is therefore of importance to select eligible patients for such a procedure. Furthermore, knowledge of the anatomical features of the occlusion may predict the chances of success of PCI CTO and could even guide the procedural strategy to augment the likelihood of recanalization. Positron emission tomography (PET) is unequivocally accepted as the reference standard for ischemia and viability testing, whereas coronary computed tomography angiography (CCTA) currently allows for non-invasive detailed three-dimensional imaging of the coronary anatomy that adds morphological information over two-dimensional ICA. Hybrid PET/CT could therefore be useful for optimal patient selection as well as procedural planning. This review discusses the potential value of PET/CT to guide PCI in CTOs.

Keywords: Chronic total occlusion; Coronary artery disease; Coronary computed tomography angiography; Invasive coronary angiography; Percutaneous coronary intervention; Positron emission tomography.

Figures

Fig. 1
Fig. 1
Proposed diagnostic and treatment algorithm in patients with a documented chronic total coronary occlusion (CTO). LV left ventricular, OMT optimal medical therapy
Fig. 2
Fig. 2
Extensive myocardial ischemia induced by a CTO LAD. Patient with a known CTO LAD for over 7 years with NYHA class II was analyzed with PET to assess the extent of myocardial ischemia before reconsidering (percutaneous) revascularization. a The proximal total occlusion of the LAD (white arrow). To appreciate collateralization, length, and course (white arrow) of the occlusion, a bilateral injection was performed during a diagnostic invasive coronary angiogram (b). PET perfusion shows the extensive (c and d) perfusion defect in presence of a proximal occlusion of the LAD. CTO chronic total occlusion, LAD left anterior descending artery, NYHA New York Heart Association, PET positron emission tomography
Fig. 3
Fig. 3
Representative cases of a false-negative and false-positive SPECT result due to limited tracer extraction or attenuation, respectively. False-negative SPECT result (a) in case of an unmistakable perfusion defect of the inferior wall on PET (b) of a patient with a chronic total occlusion (white arrow) of the RCA on ICA (c). False-positive SPECT result (d) (perfusion defect of the inferior wall) of a patient with normal perfusion on PET (e) and no obstructive coronary artery disease on ICA (f). SPECT single photon emission computed tomography, RCA right coronary artery, ICA invasive coronary angiography; other abbreviations as in Fig. 2
Fig. 4
Fig. 4
Balanced ischemia on SPECT. Example of a (nearly) normal SPECT (a) and severely reduced perfusion on positron emission tomography (PET) (b, c) in case of a significant left main stenosis (white arrow) and a chronic total occlusion of the RCA (black arrow) on invasive coronary angiography (d). SPECT is hampered by the relative nature of the images, whereas quantification with PET allows for detection of diffusely balanced ischemia. Abbreviations as in Figs. 2 and 3
Fig. 5
Fig. 5
State-of-the-art illustration of fused CCTA and PET of a CTO RCA. Relative and absolute (normal value >2.3 mL min−1 g−1 [58]) perfusion defect on H2 15O PET perfusion (a, b) fused with CCTA (c) shows the perfusion defect of the left ventricle in relation to the occluded segment of the RCA (white arrow). ICA confirmed the precise location of the coronary occlusion (white arrow) with bilateral contrast injection (d). CCTA coronary computed tomography angiography; other abbreviations as in Figs. 2 and 3
Fig. 6
Fig. 6
Myocardial viability imaging with PET. Illustration showing a mismatch of resting MBF and glucose metabolism of the inferolateral wall indicating viable myocardium (top). A matched resting perfusion and glucose metabolism defect of the inferior wall, indicating non-viable myocardium is shown in the bottom image. 82Rb82rubidium, 18F-FDG18F-deoxyglucose, SA short axis, HLA horizontal long axis, VLA vertical long axis; reprint with permission [63]
Fig. 7
Fig. 7
Viability assessment with combined PET perfusion and metabolism. Illustration of simultaneous mapping of coronary anatomy, myocardial perfusion, and metabolism. Due to fused images, it becomes possible to precisely distinguish ischemic viable form non-viable myocardium. 13NH3 13N-labeled ammonia, HU Hounsfield units; other abbreviations as in Fig. 6; reprint with permission [64]
Fig. 8
Fig. 8
Example of precise occlusion length estimation with CCTA. Three-dimensional reconstruction (a), maximum intensity projections (b), center line extraction (c), and multiplanar reconstructions (d) of CCTA accurately assesses coronary course, epicardial collaterals, plaque morphology, and occlusion length in case of a long LAD occlusion (white arrows). The occlusion length (black arrow) was confirmed with bilateral contrast injection during ICA (e). Abbreviations as in Figs. 2, 3, and 5
Fig. 9
Fig. 9
CCTA coronary course tracking. ICA of the RCA during bilateral contrast injection (a) and corresponding CCTA coronary course tracking images (b) show that the course of the occluded segment is superiorly illustrated with CCTA in comparison with ICA. Abbreviations as in Figs. 2, 3, and 5
Fig. 10
Fig. 10
CTO wire crossing difficulty score appreciated from CCTA and ICA. The top CCTA (a) and ICA (b) images display a short occlusion (<20 mm) (white arrow), tapered proximal stump, no calcification, and no bending of the occluded segment (low CT-RECTOR score). This occlusion should be approached and probably successfully crossed with antegrade wire escalation technique. The bottom CCTA (c) and ICA (d) images clearly demonstrates a long (>20 mm) (white arrow) calcified occlusion (high CT-RECTOR score) suggesting that the operator should be able to use dissection and re-entry techniques before trying to cross this occlusion because anatomy dictates which approach should be used. Abbreviations as in Figs. 2 and 3
Fig. 11
Fig. 11
Algorithm for crossing CTOs. Hybrid approach dictated by anatomical features of a chronic total occlusion of a native coronary artery. LaST limited antegrade subintimal tracking; other abbreviations as in Fig. 2; reprint with permission [••]

References

    1. Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012;59:991–7. doi: 10.1016/j.jacc.2011.12.007.
    1. Kahn JK. Angiographic suitability for catheter revascularization of total coronary occlusions in patients from a community hospital setting. Am Heart J. 1993;126:561–4. doi: 10.1016/0002-8703(93)90404-W.
    1. Werner GS, Gitt AK, Zeymer U, et al. Chronic total coronary occlusions in patients with stable angina pectoris: impact on therapy and outcome in present day clinical practice. Clin Res Cardiol. 2009;98:435–41. doi: 10.1007/s00392-009-0013-5.
    1. Christofferson RD, Lehmann KG, Martin GV, Every N, Caldwell JH, Kapadia SR. Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol. 2005;95:1088–91. doi: 10.1016/j.amjcard.2004.12.065.
    1. Stone GW, Kandzari DE, Mehran R, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation. 2005;112:2364–72. doi: 10.1161/CIRCULATIONAHA.104.481283.
    1. Zidar FJ, Kaplan BM, O’Neill WW, et al. Prospective, randomized trial of prolonged intracoronary urokinase infusion for chronic total occlusions in native coronary arteries. J Am Coll Cardiol. 1996;27:1406–12. doi: 10.1016/0735-1097(96)00010-1.
    1. Prasad A, Rihal CS, Lennon RJ, Wiste HJ, Singh M, Holmes DR., Jr Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic. J Am Coll Cardiol. 2007;49:1611–8. doi: 10.1016/j.jacc.2006.12.040.
    1. Cohen HA, Williams DO, Holmes DR, Jr, et al. Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry. Am Heart J. 2003;146:513–9. doi: 10.1016/S0002-8703(03)00259-X.
    1. Anderson HV, Shaw RE, Brindis RG, et al. A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) J Am Coll Cardiol. 2002;39:1096–103. doi: 10.1016/S0735-1097(02)01733-3.
    1. Williams DO, Holubkov R, Yeh W, et al. Percutaneous coronary intervention in the current era compared with 1985–1986: the National Heart, Lung, and Blood Institute Registries. Circulation. 2000;102:2945–51. doi: 10.1161/01.CIR.102.24.2945.
    1. Serruys PW, van Geuns RJ. Arguments for recanalization of chronic total occlusions. JACC Cardiovasc Interv. 2008;1:54–5. doi: 10.1016/j.jcin.2007.12.002.
    1. Stone GW, Colombo A, Teirstein PS, et al. Percutaneous recanalization of chronically occluded coronary arteries: procedural techniques, devices, and results. Catheter Cardiovasc Interv. 2005;66:217–36. doi: 10.1002/ccd.20489.
    1. George S, Cockburn J, Clayton TC, et al. Long-term follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database. J Am Coll Cardiol. 2014;64:235–43. doi: 10.1016/j.jacc.2014.04.040.
    1. Olivari Z, Rubartelli P, Piscione F, et al. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE) J Am Coll Cardiol. 2003;41:1672–8. doi: 10.1016/S0735-1097(03)00312-7.
    1. de Labriolle A, Bonello L, Roy P, et al. Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in “true” chronic total occlusions. Am J Cardiol. 2008;102:1175–81. doi: 10.1016/j.amjcard.2008.06.059.
    1. Valenti R, Migliorini A, Signorini U, et al. Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusion. Eur Heart J. 2008;29:2336–42. doi: 10.1093/eurheartj/ehn357.
    1. Grantham JA, Jones PG, Cannon L, Spertus JA. Quantifying the early health status benefits of successful chronic total occlusion recanalization: Results from the FlowCardia’s Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial. Circ Cardiovasc Qual Outcomes. 2010;3:284–90. doi: 10.1161/CIRCOUTCOMES.108.825760.
    1. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol. 2001;38:409–14. doi: 10.1016/S0735-1097(01)01349-3.
    1. Hoye A, van Domburg RT, Sonnenschein K, Serruys PW. Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992–2002. Eur Heart J. 2005;26:2630–6. doi: 10.1093/eurheartj/ehi498.
    1. Jaguszewski M, Targonski R, Fijalkowski M, et al. Recanalization of isolated chronic total occlusions in patients with stable angina. Int J Cardiol. 2013;167:1542–6. doi: 10.1016/j.ijcard.2012.04.097.
    1. Appleton DL, Abbate A, Biondi-Zoccai GG. Late percutaneous coronary intervention for the totally occluded infarct-related artery: a meta-analysis of the effects on cardiac function and remodeling. Catheter Cardiovasc Interv. 2008;71:772–81. doi: 10.1002/ccd.21468.
    1. Galassi AR, Tomasello SD, Reifart N, et al. In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry. EuroIntervention. 2011;7:472–9. doi: 10.4244/EIJV7I4A77.
    1. Morino Y, Kimura T, Hayashi Y, et al. In-hospital outcomes of contemporary percutaneous coronary intervention in patients with chronic total occlusion insights from the J-CTO Registry (Multicenter CTO Registry in Japan) JACC Cardiovasc Interv. 2010;3:143–51. doi: 10.1016/j.jcin.2009.10.029.
    1. Nombela-Franco L, Urena M, Jerez-Valero M, et al. Validation of the J-chronic total occlusion score for chronic total occlusion percutaneous coronary intervention in an independent contemporary cohort. Circ Cardiovasc Interv. 2013;6:635–43. doi: 10.1161/CIRCINTERVENTIONS.113.000447.
    1. Patel VG, Brayton KM, Tamayo A, et al. Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv. 2013;6:128–36. doi: 10.1016/j.jcin.2012.10.011.
    1. Grantham JA, Marso SP, Spertus J, House J, Holmes DR, Jr, Rutherford BD. Chronic total occlusion angioplasty in the United States. JACC Cardiovasc Interv. 2009;2:479–86. doi: 10.1016/j.jcin.2009.02.008.
    1. Stone GW, Reifart NJ, Moussa I, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. Circulation. 2005;112:2530–7. doi: 10.1161/CIRCULATIONAHA.105.583716.
    1. Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv. 2011;4:213–21. doi: 10.1016/j.jcin.2010.09.024.
    1. Brilakis ES, Grantham JA, Rinfret S, et al. A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC Cardiovasc Interv. 2012;5:367–79. doi: 10.1016/j.jcin.2012.02.006.
    1. Sun D, Wang J, Tian Y, et al. Multimodality imaging evaluation of functional and clinical benefits of percutaneous coronary intervention in patients with chronic total occlusion lesion. Theranostics. 2012;2:788–800. doi: 10.7150/thno.4717.
    1. Werner GS, Surber R, Ferrari M, Fritzenwanger M, Figulla HR. The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction. Eur Heart J. 2006;27:2406–12. doi: 10.1093/eurheartj/ehl270.
    1. Wright S, Lichtenstein M, Grigg L, Sivaratnam D. Myocardial perfusion imaging (MPI) is superior to the demonstration of distal collaterals in predicting cardiac events in chronic total occlusion (CTO) J Nucl Cardiol. 2013;20:563–8. doi: 10.1007/s12350-013-9678-2.
    1. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J. 2014;35:2541–619. doi: 10.1093/eurheartj/ehu278.
    1. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900–7. doi: 10.1161/01.CIR.0000072790.23090.41.
    1. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151–8. doi: 10.1016/S0735-1097(02)01726-6.
    1. Baks T, van Geuns RJ, Duncker DJ, et al. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions. J Am Coll Cardiol. 2006;47:721–5. doi: 10.1016/j.jacc.2005.10.042.
    1. Nii H, Wagatsuma K, Kabuki T, et al. Significance of percutaneous transluminal coronary intervention for chronic total occlusions assessed as non-viable by myocardial scintigraphy. J Cardiol. 2007;50:363–70.
    1. Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg. 1998;116:997–1004. doi: 10.1016/S0022-5223(98)70052-2.
    1. Di Carli MF. Predicting improved function after myocardial revascularization. Curr Opin Cardiol. 1998;13:415–24. doi: 10.1097/00001573-199811000-00006.
    1. Bax JJ, Schinkel AF, Boersma E, et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation. 2004;110:II18–22.
    1. Bonow RO. Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1159–62. doi: 10.1016/S0735-1097(02)01732-1.
    1. Beanlands RS, Nichol G, Huszti E, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2) J Am Coll Cardiol. 2007;50:2002–12. doi: 10.1016/j.jacc.2007.09.006.
    1. Holly TA, Bonow RO, Arnold JM, et al. Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the Surgical Treatment for Ischemic Heart Failure trial. J Thorac Cardiovasc Surg. 2014;148:2677–84. doi: 10.1016/j.jtcvs.2014.06.090.
    1. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283–91. doi: 10.1161/CIRCULATIONAHA.107.743963.
    1. Safley DM, Koshy S, Grantham JA, et al. Changes in myocardial ischemic burden following percutaneous coronary intervention of chronic total occlusions. Catheter Cardiovasc Interv. 2011;78:337–43.
    1. Khan MF, Wendel CS, Thai HM, Movahed MR. Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: a meta-analysis comparing successful versus failed percutaneous intervention for chronic total occlusion. Catheter Cardiovasc Interv. 2013;82:95–107. doi: 10.1002/ccd.24863.
    1. Danad I, Raijmakers PG, Knaapen P. Diagnosing coronary artery disease with hybrid PET/CT: it takes two to tango. J Nucl Cardiol. 2013;20:874–90. doi: 10.1007/s12350-013-9753-8.
    1. Maddahi J, Czernin J, Lazewatsky J, et al. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest. J Nucl Med. 2011;52:1490–8. doi: 10.2967/jnumed.111.092528.
    1. Berman DS, Maddahi J, Tamarappoo BK, et al. Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography. J Am Coll Cardiol. 2013;61:469–77. doi: 10.1016/j.jacc.2012.11.022.
    1. Nekolla SG, Reder S, Saraste A, et al. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation. 2009;119:2333–42. doi: 10.1161/CIRCULATIONAHA.108.797761.
    1. Bateman TM, Heller GV, McGhie AI, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol. 2006;13:24–33. doi: 10.1016/j.nuclcard.2005.12.004.
    1. Jaarsma C, Leiner T, Bekkers SC, et al. Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2012;59:1719–28. doi: 10.1016/j.jacc.2011.12.040.
    1. Knuuti J, Kajander S, Maki M, Ukkonen H. Quantification of myocardial blood flow will reform the detection of CAD. J Nucl Cardiol. 2009;16:497–506. doi: 10.1007/s12350-009-9101-1.
    1. Danad I, Raijmakers PG, Harms HJ, et al. Impact of anatomical and functional severity of coronary atherosclerotic plaques on the transmural perfusion gradient: a [15O]H2O PET study. Eur Heart J. 2014;35:2094–105. doi: 10.1093/eurheartj/ehu170.
    1. Kaufmann PA, Camici PG. Myocardial blood flow measurement by PET: technical aspects and clinical applications. J Nucl Med. 2005;46:75–88.
    1. Knaapen P, de HS, Hoekstra OS, et al. Cardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease. Neth Heart J. 2010;18:90–8. doi: 10.1007/BF03091744.
    1. Stuijfzand WJ, Uusitalo V, Kero T, et al. Relative flow reserve derived from quantitative perfusion imaging may not outperform stress myocardial blood flow for identification of hemodynamically significant coronary artery disease. Circ Cardiovasc Imaging. 2015; 8.
    1. Danad I, Uusitalo V, Kero T, et al. Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [(15)O]H2O PET imaging. J Am Coll Cardiol. 2014;64:1464–75. doi: 10.1016/j.jacc.2014.05.069.
    1. Choi JH, Chang SA, Choi JO, et al. Frequency of myocardial infarction and its relationship to angiographic collateral flow in territories supplied by chronically occluded coronary arteries. Circulation. 2013;127:703–9. doi: 10.1161/CIRCULATIONAHA.112.092353.
    1. Ripley DP, Gosling OE, Bhatia L, et al. The relationship between the contralateral collateral supply and myocardial viability on cardiovascular magnetic resonance: can the angiogram predict functional recovery? Int J Cardiol. 2014;177:362–7. doi: 10.1016/j.ijcard.2014.06.048.
    1. Chammas E, Hussein A, Ballane G, et al. Myocardial perfusion in patients with a totally occluded left anterior descending coronary artery reinjected by a normal right coronary artery: the role of collateral circulation. Angiology. 2008;59:464–8. doi: 10.1177/0003319707309308.
    1. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med. 1986;314:884–8. doi: 10.1056/NEJM198604033141405.
    1. Bengel FM, Higuchi T, Javadi MS, Lautamaki R. Cardiac positron emission tomography. J Am Coll Cardiol. 2009;54:1–15. doi: 10.1016/j.jacc.2009.02.065.
    1. Schwaiger M, Ziegler SI, Nekolla SG. PET/CT challenge for the non-invasive diagnosis of coronary artery disease. Eur J Radiol. 2010;73:494–503. doi: 10.1016/j.ejrad.2009.12.025.
    1. van Velzen JE, Schuijf JD, de Graaf FR, et al. Plaque type and composition as evaluated non-invasively by MSCT angiography and invasively by VH IVUS in relation to the degree of stenosis. Heart. 2009;95:1990–6. doi: 10.1136/hrt.2009.176933.
    1. Achenbach S, Marwan M, Ropers D, et al. Coronary computed tomography angiography with a consistent dose below 1 mSv using prospectively electrocardiogram-triggered high-pitch spiral acquisition. Eur Heart J. 2010;31:340–6. doi: 10.1093/eurheartj/ehp470.
    1. Springer I, Dewey M. Comparison of multislice computed tomography with intravascular ultrasound for detection and characterization of coronary artery plaques: a systematic review. Eur J Radiol. 2009;71:275–82. doi: 10.1016/j.ejrad.2008.04.035.
    1. Obaid DR, Calvert PA, Gopalan D, et al. Atherosclerotic plaque composition and classification identified by coronary computed tomography: assessment of computed tomography-generated plaque maps compared with virtual histology intravascular ultrasound and histology. Circ Cardiovasc Imaging. 2013;6:655–64. doi: 10.1161/CIRCIMAGING.112.000250.
    1. Li M, Zhang J, Pan J, Lu Z. Obstructive coronary artery disease: reverse attenuation gradient sign at CT indicates distal retrograde flow—a useful sign for differentiating chronic total occlusion from subtotal occlusion. Radiology. 2013;266:766–72. doi: 10.1148/radiol.12121294.
    1. Choi JH, Kim EK, Kim SM, et al. Noninvasive evaluation of coronary collateral arterial flow by coronary computed tomographic angiography. Circ Cardiovasc Imaging. 2014;7:482–90. doi: 10.1161/CIRCIMAGING.113.001637.
    1. Hoe J. CT coronary angiography of chronic total occlusions of the coronary arteries: how to recognize and evaluate and usefulness for planning percutaneous coronary interventions. Int J Cardiovasc Imaging. 2009;25(Suppl 1):43–54. doi: 10.1007/s10554-009-9424-7.
    1. Magro M, Schultz C, Simsek C, et al. Computed tomography as a tool for percutaneous coronary intervention of chronic total occlusions. EuroIntervention. 2010;6(Suppl G):G123–31.
    1. von Erffa J, Ropers D, Pflederer T, et al. Differentiation of total occlusion and high-grade stenosis in coronary CT angiography. Eur Radiol. 2008;18:2770–5. doi: 10.1007/s00330-008-1068-9.
    1. Mollet NR, Hoye A, Lemos PA, et al. Value of preprocedure multislice computed tomographic coronary angiography to predict the outcome of percutaneous recanalization of chronic total occlusions. Am J Cardiol. 2005;95:240–3. doi: 10.1016/j.amjcard.2004.09.009.
    1. Cho JR, Kim YJ, Ahn CM, et al. Quantification of regional calcium burden in chronic total occlusion by 64-slice multi-detector computed tomography and procedural outcomes of percutaneous coronary intervention. Int J Cardiol. 2010;145:9–14. doi: 10.1016/j.ijcard.2009.05.006.
    1. Soon KH, Cox N, Wong A, et al. CT coronary angiography predicts the outcome of percutaneous coronary intervention of chronic total occlusion. J Interv Cardiol. 2007;20:359–66. doi: 10.1111/j.1540-8183.2007.00275.x.
    1. Ehara M, Terashima M, Kawai M, et al. Impact of multislice computed tomography to estimate difficulty in wire crossing in percutaneous coronary intervention for chronic total occlusion. J Invasive Cardiol. 2009;21:575–82.
    1. Garcia-Garcia HM, van Mieghem CA, Gonzalo N, et al. Computed tomography in total coronary occlusions (CTTO registry): radiation exposure and predictors of successful percutaneous intervention. EuroIntervention. 2009;4:607–16. doi: 10.4244/EIJV4I5A102.
    1. Rolf A, Werner GS, Schuhback A, et al. Preprocedural coronary CT angiography significantly improves success rates of PCI for chronic total occlusion. Int J Cardiovasc Imaging. 2013;29:1819–27. doi: 10.1007/s10554-013-0258-y.
    1. Opolski MP, Achenbach S, Schuhback A, et al. Coronary computed tomographic prediction rule for time-efficient guidewire crossing through chronic total occlusion: insights from the CT-RECTOR multicenter registry (Computed Tomography Registry of Chronic Total Occlusion Revascularization) JACC Cardiovasc Interv. 2015;8:257–67. doi: 10.1016/j.jcin.2014.07.031.
    1. Karmpaliotis D, Green P. Chronic total occlusion percutaneous coronary intervention in 2014 beyond the J-CTO score (Japanese Multicenter CTO Registry): chance favors the prepared mind. JACC Cardiovasc Interv. 2015;8:268–70. doi: 10.1016/j.jcin.2014.08.013.

Source: PubMed

3
Se inscrever